Evaluating the safety and efficiency of cell and gene therapies requires understanding their long-term implications. This session will focus on preparing and conducting longitudinal studies, which monitor patient outcomes over long periods. Challenges include recruiting patients, maintaining data consistency, and creating useful endpoints to gauge the effectiveness of therapy. Joint attempts to standardize follow-up methods and circulate data amongst institutions can inform future therapeutic approaches.